Lipid-modifying efficacy of extended release niacin/laropiprant in Asian patients with primary hypercholesterolemia or mixed hyperlipidemia
To access this article, please choose from the options below
PII: S1933-2874(09)00195-0
doi:10.1016/j.jacl.2009.04.048
© 2009 National Lipid Association. Published by Elsevier Inc. All rights reserved.
